| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |